Best Practices, LLC Research Reflects on Critical Role of Medical Marketing in New Product Launch Success

Jun 23, 2010, 13:53 ET from Best Practices, LLC

CHAPEL HILL, N.C., June 23 /PRNewswire/ -- Leading pharmaceutical and biotech companies rely on their New Product Planning teams to help deliver effective new products in shorter time frames while minimizing development costs. The New Product Planning (NPP) function is key to that effort as it seeds the development cycle with commercial insights to help drive not only the development process but also a successful launch.

Medical Marketing activities such as advisory boards and thought leader identification and management are vital aspects of the product development function. The Best Practices, LLC benchmarking report New Product Planning: Role and Activities for Medical Marketing presents an overview of the role of medical marketing in the new product development process. In addition, this study provides a detailed examination of the timing and value of critical Medical Marketing activities. Executives and managers can use this study to inform and shape their thinking around the challenges of Medical Marketing activities for new product development.

Key topics in this 50-slide report are:

  • The current state of New Product Planning in pharma
  • Overview of New Product Planning activities and timing during development process
  • Review the main Medical Marketing activities carried out during the development process and drill down on their timing, intended outcomes, and value for the organization

To download a complimentary study excerpt, go to:

http://www3.best-in-class.com/rr1008.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 27 New Product Planning leaders at 25 pharma companies across the globe contributed data. In-depth interviews were conducted with leaders from 13 of the participating companies. The research report reflects the current state of New Product Planning efforts at best-in-class organizations such as Abbott, Astellas, Bayer, Daiichi Sankyo, Eli Lilly, Merck, Novartis, sanofi aventis, Wyeth and others.

To learn more about Best Practices' other timely research visit: http://www3.best-in-class.com or contact Jeff Zimmer at 919-767-9180 or jzimmer@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 

SOURCE Best Practices, LLC



RELATED LINKS

http://www.best-in-class.com